Immune
A comprehensive summary of LL-37, the factotum human cathelicidin peptide
Vandamme D, Landuyt B, Luyten W, Schoofs L. · Cell Immunol · 2012
PMID: 22249267 · DOI: 10.1016/j.cellimm.2012.02.005
Summary
Mechanistic review of LL-37 as a multitask host-defense peptide spanning antimicrobial activity, LPS neutralization, chemotaxis, and re-epithelialization across in vitro and animal models.
Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.
Compounds referenced in this study
- View product →LL-3737-residue human cathelicidin antimicrobial peptide studied in innate-immunity and wound-healing research.
Guides covering this compound
More Immune citations
- The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trialCrit Care · 2013
- The efficacy and safety of thymosin alpha-1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trialBMJ · 2025
- Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trialLiver · 1996